We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$98.4B
AUM Growth
-$2.76B
Cap. Flow
-$1.74B
Cap. Flow %
-1.77%
Top 10 Hldgs %
21.87%
Holding
3,216
New
68
Increased
954
Reduced
1,923
Closed
84

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$106M
2
CRH icon
CRH
CRH
+$105M
3
AMZN icon
Amazon
AMZN
+$102M
4
AAPL icon
Apple
AAPL
+$98.1M
5
SLV icon
iShares Silver Trust
SLV
+$83.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$321M
2
UBS icon
UBS Group
UBS
+$312M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$278M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$212M
5
MELI icon
Mercado Libre
MELI
+$183M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Healthcare 15%
3 Financials 13.74%
4 Consumer Discretionary 9.98%
5 Industrials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUTX
3001
Nutex Health
NUTX
$1.06B
$73.2K ﹤0.01%
2,411
-128
-5% -$6.17K
CRBU icon
3002
Caribou Biosciences
CRBU
$160M
$72.6K ﹤0.01%
+15,188
New +$94.2K
TMC icon
3003
TMC The Metals Company
TMC
$1.79B
$63.3K ﹤0.01%
+63,896
New +$91.8K
CRDL
3004
Cardiol Therapeutics
CRDL
$158M
$62K ﹤0.01%
+50,000
New +$47.8K
GOTU icon
3005
Gaotu Techedu
GOTU
$453M
$54.7K ﹤0.01%
19,812
+3,593
+22% +$11.2K
BTAI icon
3006
BioXcel Therapeutics
BTAI
$25.3M
$54.5K ﹤0.01%
1,347
-619
-31% -$62.6K
BDTX icon
3007
Black Diamond Therapeutics
BDTX
$108M
$51.7K ﹤0.01%
+18,000
New +$66.3K
STOK icon
3008
Stoke Therapeutics
STOK
$2.05B
$49K ﹤0.01%
12,449
-1,062
-8% -$6.98K
VNET
3009
VNET Group
VNET
$2.01B
$47.6K ﹤0.01%
15,213
– –
CANO
3010
DELISTED
Cano Health, Inc.
CANO
$47.4K ﹤0.01%
1,868
-113
-6% -$9.29K
API
3011
Agora
API
$350M
$43.8K ﹤0.01%
17,300
-100
-0.6% -$287
TEF
3012
DELISTED
Telefonica
TEF
$43.2K ﹤0.01%
+10,603
New +$42.9K
HYLN icon
3013
Hyliion Holdings
HYLN
$713M
$35.3K ﹤0.01%
29,931
+7,393
+33% +$11.1K
VRM icon
3014
Vroom Inc
VRM
$50.9M
$32.5K ﹤0.01%
363
-85
-19% -$10.7K
ABSI icon
3015
Absci
ABSI
$1.41B
$30.3K ﹤0.01%
22,945
+6,305
+38% +$11K
CAN
3016
Canaan Creative
CAN
$149M
$29.8K ﹤0.01%
16,400
– –
GMDA
3017
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$27.8K ﹤0.01%
27,000
-20,500
-43% -$26.2K
BNAIW
3018
Brand Engagement Network Warrant
BNAIW
$1.82M
$26.7K ﹤0.01%
26,666
– –
ESPR
3019
DELISTED
Esperion Therapeutics
ESPR
$17.4K ﹤0.01%
17,728
-2,579
-13% -$3.73K
INO icon
3020
Inovio Pharmaceuticals
INO
$68.5M
$13.7K ﹤0.01%
2,938
-1,812
-38% -$10K
CRGE
3021
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$11.8K ﹤0.01%
23,738
– –
AMRN
3022
Amarin Corp
AMRN
$305M
$10.5K ﹤0.01%
568
– –
DOYU
3023
DouYu International Holdings
DOYU
$143M
$10.4K ﹤0.01%
1,067
– –
ACDC icon
3024
ProFrac Holding
ACDC
$827M
– –
-41,451
Closed -$463K
AGG icon
3025
iShares Core US Aggregate Bond ETF
AGG
$137B
– –
-89,177
Closed -$8.73M
119 120
121
122 123

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q3 2023 Portfolio in Review

As of Q3 2023, Credit Suisse held 3,216 positions worth $98.4B, down 2.7% from $101B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.7%. Credit Suisse opened 68 new positions and exited 84, leaving the 3,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2023 buy was CRH: 1,849,255 shares worth $101M.
  • Credit Suisse added most to Alibaba in Q3 2023, an estimated $106M increase.
  • Credit Suisse's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $321M.
  • Credit Suisse fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $24.8M.
  • Credit Suisse's ten largest holdings make up 22% of its $98.4B portfolio in Q3 2023.
  • Credit Suisse opened 68 new positions and closed 84 in Q3 2023.
  • Credit Suisse's portfolio value fell 2.7% quarter-over-quarter to $98.4B.

Based on Credit Suisse's 13F filing for Q3 2023, filed 13 Nov 2023.